Bayer AG
XETRA:BAYN
Bayer AG
XETRA:BAYN
Price:
27.98 EUR
-0.53%
Updated:
May 3, 2024
Bayer AG
Total Equity
|
Bayer AG
Total Equity Peer Comparison
Comparables:
ATAI
MRK
93M1
DMP
PSG
Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Bayer AG
XETRA:BAYN
|
Total Equity
€32.9B
|
CAGR 3-Years
3%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
5%
|
|
|
ATAI Life Sciences NV
NASDAQ:ATAI
|
Total Equity
$243m
|
CAGR 3-Years
39%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Merck KGaA
XETRA:MRK
|
Total Equity
€26.7B
|
CAGR 3-Years
16%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
|
MPH Health Care AG
XETRA:93M1
|
Total Equity
€192.3m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
|
|
Dermapharm Holding SE
XETRA:DMP
|
Total Equity
€539.2m
|
CAGR 3-Years
19%
|
CAGR 5-Years
16%
|
CAGR 10-Years
N/A
|
|
|
PharmaSGP Holding SE
XETRA:PSG
|
Total Equity
€31.1m
|
CAGR 3-Years
-31%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
N/A
|
See Also
What is Bayer AG's Total Equity?
Total Equity
32.9B
EUR
32.9B
EUR
Based on the financial report for Dec 31, 2023, Bayer AG's Total Equity amounts to 32.9B EUR.
What is Bayer AG's Total Equity growth rate?
Total Equity CAGR 10Y
5%
5%
Over the last year, the Total Equity growth was -15%. The average annual Total Equity growth rates for Bayer AG have been 3% over the past three years , -6% over the past five years , and 5% over the past ten years .
You don't have any saved screeners yet
